Clinical trial
Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study
NCT02582424 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Safety and Efficacy of PDL-0101 in Patients With Hyperlipidemias: a Pilot Study
- Lead sponsor
- Primus Pharmaceuticals
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- July 31, 2012
- Completion date
- September 30, 2013
- Enrollment
- 103 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hyperlipidemia